IR NewsInvestors

Investors
2022 IR News

IR News 2022

Aug 05, 2022

FINANCIALS

FY2022 Q2 Presentation

Aug 05, 2022

FINANCIALS

Consolidated Financial Results for the Second Quarter of the Year Ending December 31, 2022

May 30, 2022

ANNOUNCEMENT

Carna Announces Clearance of IND to Initiate Phase 1b Study of AS-1763 in the U.S.

May 10, 2022

FINANCIALS

FY2022 Q1 Presentation

May 10, 2022

FINANCIALS

Revision of Results Forecast for the Fiscal Year Ending December 31, 2022

May 10, 2022

FINANCIALS

Consolidated Financial Results for the First Quarter of the Year Ending December 31, 2022

Apr 15, 2022

ANNOUNCEMENT

Gilead Presented a Novel DGKα Inhibitor Licensed from Carna

Apr 12, 2022

ANNOUNCEMENT

Carna Presented AS-1763 Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

Mar 28, 2022

NEWS

Research report from Shared Research has been updated.

Mar 18, 2022

ANNOUNCEMENT

Carna Receives the First Milestone Payment from BioNova following the Clearance of Investigational New Drug Application for AS-1763 (BN102) in China

Feb 10, 2022

ANNOUNCEMENT

Corporate Presentation Feb. 2022

Feb 10, 2022

FINANCIALS

FY2021 Presentation

Feb 10, 2022

FINANCIALS

Consolidated Financial Results for the Year Ended December 31, 2021

Feb 02, 2022

ANNOUNCEMENT

Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences

Jan 05, 2022

ANNOUNCEMENT

Submission of Investigational New Drug Application for AS-1763 (BN102) in China by BioNova